ERC 5-year Impact Factor
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Endocrine-Related Cancer 16 (4) 1251 -1260     DOI: 10.1677/ERC-09-0036
Copyright © 2009 by the Society for Endocrinology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ERC-09-0036v1
16/4/1251    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiore, E
Right arrow Articles by Vitti, P
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiore, E
Right arrow Articles by Vitti, P

Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role

E Fiore, T Rago, M A Provenzale, M Scutari, C Ugolini1, F Basolo1, G Di Coscio2, P Berti 3, L Grasso, R Elisei, A Pinchera and P Vitti

Department of Endocrinology
1 Section of Pathology
2 , Section of Cytopathology
3 Department of Surgery, University of Pisa, via Paradisa 2, 56100 Pisa, Italy

(Correspondence should be addressed to E Fiore; Email: e.fiore{at}ao-pisa.toscana.it)

Higher TSH values, even within normal ranges, have been associated with a greater risk of thyroid malignancy. The relationship between TSH and papillary thyroid cancer (PTC) has been analyzed in 10 178 patients submitted to fine needle aspiration of thyroid nodules with a cytology of PTC (n=497) or benign thyroid nodular disease (BTND, n=9681). In 942 patients, submitted to surgery (521 from BTND and 421 from PTC), the histological diagnosis confirmed an elevated specificity (99.6%) and sensitivity (98.1%) of cytology. TSH levels were significantly higher in PTC than in BTND both in the cytological and histological series and also in patients with a clinical diagnosis of multinodular goiter (MNG) and single/isolate nodule (S/I). A significant age-dependent development of thyroid autonomy (TSH <0.4 µU/ml) was observed in patients with benign thyroid disease, but not in those with PTC, diagnosed both on cytology and histology. In patients with MNG, the frequency of thyroid autonomy was higher and the risk of PTC was lower compared to those with S/I. In all patients, the presence of thyroid auto-antibodies (TAb) was associated with a significant increase of TSH. However, both in TAb positive and TAb negative patients TSH levels were significantly higher in PTC than in BTND. Our data confirm a direct relationship between TSH levels and risk of PTC in patients with nodular thyroid diseases. Thyroid autonomy conceivably protects against the risk of PTC, while thyroid autoimmunity does not play a significant role.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
B. Biondi
Thyroid and Obesity: An Intriguing Relationship
J. Clin. Endocrinol. Metab., August 1, 2010; 95(8): 3614 - 3617.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
T Rago, E Fiore, M Scutari, F Santini, G Di Coscio, R Romani, P Piaggi, C Ugolini, F Basolo, P Miccoli, et al.
Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease
Eur. J. Endocrinol., April 1, 2010; 162(4): 763 - 770.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
E Fiore, T Rago, M A Provenzale, M Scutari, C Ugolini, F Basolo, G Di Coscio, P Miccoli, L Grasso, A Pinchera, et al.
L-thyroxine-treated patients with nodular goiter have lower serum TSH and lower frequency of papillary thyroid cancer: results of a cross-sectional study on 27 914 patients
Endocr. Relat. Cancer, February 18, 2010; 17(1): 231 - 239.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
K. Boelaert
The association between serum TSH concentration and thyroid cancer
Endocr. Relat. Cancer, December 1, 2009; 16(4): 1065 - 1072.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the Society for Endocrinology.